Structure-function aspects of prion proteins

Current Opinion in Biotechnology

Volumn 9, Issue 4, 1998, Pages 359-365

  Daggett, Valerie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

CONFORMATIONAL TRANSITION; NERVE DEGENERATION; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SCRAPIE; STRUCTURE ACTIVITY RELATION;

EID: 0032146792     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80008-6     Document Type: Article

References (58)

1. Prusiner SB. Molecular biology of prion diseases. Science. 252:1991;1515-1522.
2. Prusiner SB. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci. 21:1996;482-487.
3. DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion diseases. Am J Pathol. 146:1995;785-811.
4. Brown P, Preece MA, Will RG. 'Friendly fire' in medicine. Lancet. 340:1992;24-27.
5. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
6. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 383:1996;685-690.
7. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450.
8. Raymond GJ, Hope J, Kocisko DA, Pnola SA, Raymond LD, Bossers A, Ironside J, Will RG, Chen SG, Petersen RB. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature. 388:1997;285-288.
9. Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame A, Prusiner SB. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 32:1993;1991-2002.
10. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-sensitive and phospholipase-sensitive. J Biol Chem. 266:1991;18217-18223.
11. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA. 90:1993;10962-10966.
12. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ. Scrapie prion proteins are synthesized in neurons. Am J Pathol. 122:1986;1-5.
13. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 30:1991;7672-7680.
14. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. Thermal stability and conformational transition of scrapie amyloid (prion) protein correlate with infectivity. Protein Sci. 2:1993;2206-2216.
15. Gasset M, Baldwin MA, Lloyd DH, Gabriel JM, Holtzman DM, Cohen FE, Fletterick R, Prusiner SB. Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci USA. 89:1992;10940-10944.
16. Sc: an α-helix to β-sheet transition. Phil Trans R Soc Lond B. 343:1994;435-441.
17. Nguyen J, Baldwin MA, Cohen FE, Prusiner SB. Prion protein peptides induce α-helix to β-sheet conformational transitions. Biochemistry. 34:1995;4186-4192.
18. Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413:1997;282-288.
19. James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne D, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, Cohen FE. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci USA. 94:1997;10086-10091.
20. Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE, Prusiner SB, Wright PE, Dyson HJ. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA. 94:1997;13452-13457.
21. Prusiner SB. Biology and genetics of prion diseases. Annu Rev Microbiol. 48:1994;655-686.
22. Prusiner SB. Prion diseases and the BSE crisis. Science. 278:1997;245-251.
23. Baldwin M, Cohen FE, Prusiner SB. Prion protein isoforms a convergence of biological and structural investigations. J Biol Chem. 270:1995;19197-19200.
24. Caughey B, Chesebro B. Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol. 7:1997;56-62.
25. Harrison PM, Bamborough P, Daggett V, Prusiner SB, Cohen FE. The prion folding problem. Curr Opin Struct Biol. 7:1997;53-59.
26. Zhang H, Stockel J, Melholrn I, Groth D, Baldwin MA, Prusiner SB, James TL, Cohen FE. Physical studies of conformational plasticity in a recombinant prion protein. Biochem. 36:1997;3543-3553.
27. Swietnicki W, Petersen R, Gambetti P, Surewicz WK. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem. 272:1997;27517-27520.
28. Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K. NMR structure of the mouse prion protein domain PrP (121-231). Nature. 382:1996;180-182.
29. Zhang H, Kaneko K, Nguyen JT, Livshits TL, Baldwin MA, Cohen FE, James TL, Prusiner SB. Conformational transitions in peptides containing two putative α-helices of the prion protein. J Mol Biol. 250:1995;514-526.
30. Borcheit DR, Sisodia SS. Loss of functional prion protein: a role in prion disorders. Chem Biol. 3:1996;619-621.
31. Hornshaw MP, McDermott JR, Candy JM. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Comm. 207:1995;621-629.
32. Miura T, Hori-i A, Takeuchi H. Metal-dependent α-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett. 396:1996;248-252.
33. Brown DR, Schmidt B, Kretzschmar HA. Effects of copper on survival of prion protein knockout neurons and glia. J Neurochem. 70:1998;1686-1693.
34. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Stronte R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, et al. The cellular prion protein binds copper in vivo. Nature. 390:1997;684-687.
35. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol. 146:1997;104-112.
36. Peretz D, Williamson RA, Matsunaga Y, Serban H, Pinilla C, Bastidas RB, Rozenshteyn R, James TL, Houghten RA, Cohen FE, et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol. 273:1997;614-622.
37. Speed MA, Wang DIC, King J. Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol. 14:1996;1283-1287.
38. Fink AL. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des. 3:1998;R9-R23.
39. Sc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
40. Lehmann S, Harris DA. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem. 272:1997;21479-21487.
41. O'Connor SE, Imperiali B. Modulation of protein structure and function by asparagine-linked glycosylation. Chem Biol. 3:1996;803-812.
42. Kaneko K, Vey M, Scott M, Pilkuhn S, Cohen RD, Prusiner SB. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci USA. 94:1997;2333-2338.
43. Daude N, Lehmann S, Harris DA. Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells. J Biol Chem. 272:1997;11604-11612.
44. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR. A transmembrane form of the prion protein in neurodegenerative disease. Science. 279:1998;827-834.
45. Pillot T, Lins L, Goethals M, Vanloo B, Baert J, Vandekerckhove J, Rosseneu M, Brasseur R. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J Mol Biol. 274:1997;381-393.
46. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 370:1994;471-474.
47. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB. Evidence for the conformational of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science. 274:1996;2079-2082.
48. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen RD, Prusiner SB. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA. 94:1997;10069-10074.
49. DebBurman S, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA. 94:1997;13938-13943.
50. Billeter M, Riek R, Wider G, Hornemann S, Glockshuber R, Wuthrich K. Prion protein NMR structure and species barrier for prion diseases. Proc Natl Acad Sci USA. 94:1997;7281-7285.
51. Scott MR, Safar J, Telling G, Nguyen O, Groth D, Torchia M, Koehler R, Tremblay P, Walther D, Cohen FE, et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prisons to transgenic mice. Proc Natl Acad Sci USA. 94:1997;14279-14284.
52. Bossers A, Belt PBGM, Raymond GJ, Caughey B, DeVries R, Smits MA. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. Proc Natl Acad Sci USA. 94:1997;4931-4936.
53. Kocisko DA, Priola SA, Raymond GJ, Chesebro B, Lansbury PT Jr, Caughey B. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proc Natl Acad Sci USA. 92:1995;3923-3927.
54. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature. 375:1995;698-700.
55. Endo T, Groth D, Prusiner SB, Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry. 28:1989;8380-8388.
56. Sc diversity and protein - protein interactions.
57. Kraulis PJ. MolScript: a program to produce both detailed and schematic plots of protein structure. J Appl Crystallogr. 24:1991;946-950.
58. Ferrin TE, Huang CC, Jarvis LE, Langridge R. The MIDAS display system. J Mol Graphics. 6:1988;13-27.